Protagenic Therapeutics Inc (NASDAQ:PTIX)

0.6355
BATS BZX Real-Time Price
As of 3:16pm ET
 -0.0279 / -4.21%
Today’s Change
0.56
Today|||52-Week Range
2.35
-54.12%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$11.7M

Company Description

Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.

Contact Information

Protagenic Therapeutics, Inc.
149 Fifth Avenue
New York New York 10010
P:(212) 994-8200
Investor Relations:
(213) 260-4342

Employees

Shareholders

Mutual fund holders2.06%
Individual stakeholders17.98%
Other institutional1.44%

Top Executives

Andrew SleeChief Operating Officer
Alexander K. ArrowChief Financial Officer
Robert Benjamin SteinDirector & Chief Medical Officer
Christina FaragallaDirector-Project Management